Form D · Other

Project Nootropic Ltd

London, X0 · CIK 0002080713

Offering snapshot reported Jul 15, 2026 · SEC filing

Reported sold
$1.09M
Offering amount: $1.09M
Investors reported
15
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 26, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$543K$1.09MJun 8, 2026: $1,067,520.00Jun 8, 2026Jul 15, 2026: $1,086,720.00Jul 15, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,067,520 → $1,086,720
  • Reported investors13 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 15, 2026Amendment$1,086,720$19,200vs Jun 8, 202615SEC filing
Jun 8, 2026Initial$1,067,520No comparison13SEC filing
Aug 11, 2025Initial$1,920,000No comparison38SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-586576

Source: Form D, filed Jul 15, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Luke Thomas Betts Director

Issuer details

Industry: Other (See others in industry)

Address:
Klaco House, Third Floor 28 St. John's Square
London, X0, EC1M4DN